90. 網膜色素変性症 Retinitis pigmentosa Clinical trials / Disease details
臨床試験数 : 130 / 薬物数 : 180 - (DrugBank : 41) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 109
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04252534 (ClinicalTrials.gov) | January 1, 2017 | 31/1/2020 | Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma | Management of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich Plasma | Retinitis Pigmentosa | Combination Product: PRP combined Magnovision;Biological: PRP | Ankara Universitesi Teknokent | NULL | Completed | 18 Years | 60 Years | All | 60 | N/A | NULL |